Tianda Pharmaceuticals Limited (HKG:0455)

Market Cap	322.51M
Revenue (ttm)	329.94M
Net Income (ttm)	-61.37M
Shares Out	2.15B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (3.47%)
Ex-Dividend Date	Jun 13, 2024

Volume	136,000
Average Volume	62,700
Open	0.1510
Previous Close	0.1500
Day's Range	0.1500 - 0.1510
52-Week Range	0.1300 - 0.2750
Beta	-0.12
RSI	46.48
Earnings Date	May 28, 2025

About Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products foc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 701
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0455

Financial Performance

In 2024, Tianda Pharmaceuticals's revenue was 329.94 million, a decrease of -37.99% compared to the previous year's 532.09 million. Losses were -61.37 million, 154.1% more than in 2023.